Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
Costa E, Pereira BJ, Rocha-Pereira P, Rocha S, Reis F, Castro E, Teixeira F, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
Costa E, et al. Among authors: rocha s, rocha pereira p.
Am J Nephrol. 2008;28(4):677-83. doi: 10.1159/000121478. Epub 2008 Mar 20.
Am J Nephrol. 2008.
PMID: 18354252